May 12 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2023 Mar 31, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 90 mln 109 mln 400 mln
(-18.0 pct) (+22.3 pct) (-10.7 pct)
Operating loss 101 mln loss 37 mln loss 1.40
Recurring loss 101 mln loss 26 mln loss 1.41
Net loss 97 mln loss 21 mln loss 1.39
EPS loss 3.14 yen loss 0.74 yen loss 44.60 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T